콘텐츠로 건너뛰기
Merck
  • Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology.

Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology.

Neurobiology of aging (2014-10-16)
David A Dyment, Amanda C Smith, Peter Humphreys, Jeremy Schwartzentruber, Chandree L Beaulieu, Dennis E Bulman, Jacek Majewski, John Woulfe, Jean Michaud, Kym M Boycott
초록

The tauopathies are a heterogeneous group of neurodegenerative disorders characterized by the shared presence of tau aggregates and neurofibrillary tangles within the central nervous system. Here, we present a child with a severe neurodegenerative disorder characterized by intractable seizures and significant tau-immunoreactive neurofibrillary degeneration localized predominantly to the substantia nigra on neuropathology with absence of beta-amyloid plaques and Lewy or Pick bodies. Whole-exome sequencing identified a homozygous truncating mutation in Synaptojanin 1 (SYNJ1). Quantitative polymerase chain reaction and Western blot experiments demonstrated diminished SYNJ1 messenger RNA and protein. Knockout Synj1(-/-) mice have convulsions and die early in life. More recently, homozygous missense mutations have been reported in 2 families with early-onset parkinsonism and seizures. Our findings broaden the spectrum of disease associated with alteration of SYNJ1 and further implicate defects in synaptic vesicle recycling in the tauopathies.